LSD1 (lysine-specific demethylase 1) and HDAC6 selective dual inhibitors exerted synergistic effects in a xenograft model of multiple myeloma, exhibiting better effects than treatment with the single agent [57]. Here, HDAC6 is linked to AL amyloidosis.